Catherine C Mcgowan, MD | |
3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 | |
(615) 322-3000 | |
Not Available |
Full Name | Catherine C Mcgowan |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205819695 | NPI | - | NPPES |
3066663 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD0000021275 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Catherine C Mcgowan, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: (615) 936-2000 | Catherine C Mcgowan, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
Weight loss at high altitudes-something universally experienced by climbers and people who move to higher terrain-may not be a detrimental effect, but rather is likely an evolutionarily-programmed adaptation, according to a new article in BioEssays.
Scientists at Forsyth may have moved one step closer to regenerating human spinal cord tissue by artificially inducing a frog tadpole to re-grow its tail at a stage in its development when it is normally impossible. Using a variety of methods including a kind of gene therapy, the scientists altered the electrical properties of cells thus inducing regeneration.
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
A third of adult leukemia patients given the novel drug quizartinib during a phase II study have achieved a composite response of either complete remission, or remission with incomplete platelet recovery or incomplete hematologic recovery, report US researchers.
Researchers at the Université libre de Bruxelles, ULB define for the first time how the cancer cell of origin controls invasive and metastatic properties of tumor cells.
› Verified 9 days ago
Megan Desai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Infectious Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Infectious Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |